Chronic Heart Failure, Multidisciplinary Communication, Nurse's Role
Conditions
Brief summary
This study aimed to evaluate the feasibility and effectiveness of a nurse-led multidisciplinary precision care in early cardiac rehabilitation of patients with chronic heart failure, and further to promote the application of nurse-led multidisciplinary precision care.
Detailed description
Enrolled patients were randomly divided as 1:1 ratio to experimental group and control group, while experimental group received nurse-led multidisciplinary precision care and the control group received standard care according to guidelines. The primary and secondary outcomes were evaluated and analyzed.
Interventions
OTHERmultidisciplinary precision care
The experimental group received precision nursing based on a multidisciplinary collaborative team in addition to standard treatment and care
Sponsors
Zhongshan People's Hospital, Guangdong, China
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Aged from 18 to 80 years; * Conscious, with normal cognitive function and being communicable; * NYHA heart function class II-IV; * Patients met the diagnostic criteria of the clinical guidelines for the diagnosis and treatment of heart failure and were diagnosed with chronic heart failure; * Informed consent was obtained.
Exclusion criteria
* Patients with congenital heart disease, cardiac shock, or persistent hypotension; * Patients with severe liver and kidney dysfunction, moderate to severe anemia or coagulation disorders, and other serious systemic complications; * Patients with a history of mental illness, a state of severe anxiety or depression, cognitive or communication impairments, and inability to communicate and respond to investigations; * Patients have been involved in other research that would interfere with this study; * Patients who declined cardiac rehabilitation and signed informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| left ventricular ejection fraction | baseline, pre-intervention, 1 month after intervention, 3 months after intervention |
| 6-minute walking distance | baseline, pre-intervention, 1 month after intervention, 3 months after intervention |
Secondary
| Measure | Time frame |
|---|---|
| the European Organization for Research and Treatment of Cancer (EORTC) quality-of-life (QoL) questionnaires (QLQ) QLQ-C30 (version 3.0) score Quality of Life | baseline, pre-intervention, 1 month after intervention, 3 months after intervention |
| Symptom Check List-90 | baseline, pre-intervention, 1 month after intervention, 3 months after intervention |
| Performance Status Score | baseline, pre-intervention, 1 month after intervention, 3 months after intervention |
| Numbers of patients with cardiovascular complications | baseline, pre-intervention, 1 month after intervention, 3 months after intervention |
Countries
China
Outcome results
None listed